nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.0192	0.0757	CcSEcCtD
Pethidine—GRIN2C—nerve—amyotrophic lateral sclerosis	0.0165	0.0566	CbGeAlD
Pethidine—GRIN2B—nerve—amyotrophic lateral sclerosis	0.0131	0.0447	CbGeAlD
Pethidine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0516	CcSEcCtD
Pethidine—GRIN2C—hindbrain—amyotrophic lateral sclerosis	0.0124	0.0424	CbGeAlD
Pethidine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0455	CcSEcCtD
Pethidine—GRIN2D—hindbrain—amyotrophic lateral sclerosis	0.0115	0.0394	CbGeAlD
Pethidine—GRIN2A—nerve—amyotrophic lateral sclerosis	0.0114	0.0391	CbGeAlD
Pethidine—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0412	CcSEcCtD
Pethidine—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0412	CcSEcCtD
Pethidine—GRIN1—hindbrain—amyotrophic lateral sclerosis	0.0103	0.0351	CbGeAlD
Pethidine—GRIN2B—hindbrain—amyotrophic lateral sclerosis	0.00979	0.0335	CbGeAlD
Pethidine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00914	0.0361	CcSEcCtD
Pethidine—GRIN2A—hindbrain—amyotrophic lateral sclerosis	0.00856	0.0293	CbGeAlD
Pethidine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.008	0.0316	CcSEcCtD
Pethidine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00759	0.03	CcSEcCtD
Pethidine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00718	0.0284	CcSEcCtD
Pethidine—GRIN2C—brainstem—amyotrophic lateral sclerosis	0.0071	0.0243	CbGeAlD
Pethidine—OPRM1—nerve—amyotrophic lateral sclerosis	0.00695	0.0238	CbGeAlD
Pethidine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00675	0.0267	CcSEcCtD
Pethidine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00662	0.0262	CcSEcCtD
Pethidine—GRIN2D—brainstem—amyotrophic lateral sclerosis	0.0066	0.0226	CbGeAlD
Pethidine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.0063	0.0216	CbGeAlD
Pethidine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00615	0.0243	CcSEcCtD
Pethidine—GRIN1—brainstem—amyotrophic lateral sclerosis	0.00588	0.0201	CbGeAlD
Pethidine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00566	0.0224	CcSEcCtD
Pethidine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00562	0.0222	CcSEcCtD
Pethidine—GRIN2B—brainstem—amyotrophic lateral sclerosis	0.00561	0.0192	CbGeAlD
Pethidine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00557	0.022	CcSEcCtD
Pethidine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0214	CcSEcCtD
Pethidine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0214	CcSEcCtD
Pethidine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.0054	0.0214	CcSEcCtD
Pethidine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00521	0.0206	CcSEcCtD
Pethidine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00509	0.0174	CbGeAlD
Pethidine—GRIN2C—medulla oblongata—amyotrophic lateral sclerosis	0.00495	0.0169	CbGeAlD
Pethidine—GRIN2A—brainstem—amyotrophic lateral sclerosis	0.00491	0.0168	CbGeAlD
Pethidine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00472	0.0162	CbGeAlD
Pethidine—Methylphenobarbital—GRIA2—amyotrophic lateral sclerosis	0.00471	1	CrCbGaD
Pethidine—GRIN2D—medulla oblongata—amyotrophic lateral sclerosis	0.0046	0.0157	CbGeAlD
Pethidine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00433	0.0148	CbGeAlD
Pethidine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00421	0.0167	CcSEcCtD
Pethidine—GRIN2D—spinal cord—amyotrophic lateral sclerosis	0.0041	0.014	CbGeAlD
Pethidine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0159	CcSEcCtD
Pethidine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00393	0.0155	CcSEcCtD
Pethidine—GRIN2C—nervous system—amyotrophic lateral sclerosis	0.00372	0.0127	CbGeAlD
Pethidine—GRIN1—spinal cord—amyotrophic lateral sclerosis	0.00366	0.0125	CbGeAlD
Pethidine—GRIN2C—central nervous system—amyotrophic lateral sclerosis	0.00358	0.0123	CbGeAlD
Pethidine—GRIN2C—cerebellum—amyotrophic lateral sclerosis	0.0035	0.012	CbGeAlD
Pethidine—GRIN2B—spinal cord—amyotrophic lateral sclerosis	0.00349	0.0119	CbGeAlD
Pethidine—GRIN2D—nervous system—amyotrophic lateral sclerosis	0.00346	0.0118	CbGeAlD
Pethidine—GRIN2A—medulla oblongata—amyotrophic lateral sclerosis	0.00342	0.0117	CbGeAlD
Pethidine—GRIN2D—central nervous system—amyotrophic lateral sclerosis	0.00333	0.0114	CbGeAlD
Pethidine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0033	0.013	CcSEcCtD
Pethidine—GRIN2D—cerebellum—amyotrophic lateral sclerosis	0.00325	0.0111	CbGeAlD
Pethidine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0127	CcSEcCtD
Pethidine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0125	CcSEcCtD
Pethidine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00309	0.0122	CcSEcCtD
Pethidine—GRIN1—nervous system—amyotrophic lateral sclerosis	0.00308	0.0105	CbGeAlD
Pethidine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00308	0.0122	CcSEcCtD
Pethidine—GRIN2A—spinal cord—amyotrophic lateral sclerosis	0.00305	0.0104	CbGeAlD
Pethidine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00304	0.012	CcSEcCtD
Pethidine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00302	0.0119	CcSEcCtD
Pethidine—OPRM1—brainstem—amyotrophic lateral sclerosis	0.00298	0.0102	CbGeAlD
Pethidine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00298	0.0118	CcSEcCtD
Pethidine—GRIN1—central nervous system—amyotrophic lateral sclerosis	0.00297	0.0102	CbGeAlD
Pethidine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0117	CcSEcCtD
Pethidine—GRIN2B—nervous system—amyotrophic lateral sclerosis	0.00294	0.0101	CbGeAlD
Pethidine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00291	0.0115	CcSEcCtD
Pethidine—GRIN1—cerebellum—amyotrophic lateral sclerosis	0.0029	0.00992	CbGeAlD
Pethidine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0113	CcSEcCtD
Pethidine—GRIN2C—brain—amyotrophic lateral sclerosis	0.00284	0.00973	CbGeAlD
Pethidine—GRIN2B—central nervous system—amyotrophic lateral sclerosis	0.00283	0.00969	CbGeAlD
Pethidine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0112	CcSEcCtD
Pethidine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0111	CcSEcCtD
Pethidine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0111	CcSEcCtD
Pethidine—GRIN2B—cerebellum—amyotrophic lateral sclerosis	0.00277	0.00947	CbGeAlD
Pethidine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0109	CcSEcCtD
Pethidine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0108	CcSEcCtD
Pethidine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0107	CcSEcCtD
Pethidine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00271	0.00926	CbGeAlD
Pethidine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0106	CcSEcCtD
Pethidine—GRIN2D—brain—amyotrophic lateral sclerosis	0.00264	0.00904	CbGeAlD
Pethidine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00262	0.0104	CcSEcCtD
Pethidine—GRIN2A—nervous system—amyotrophic lateral sclerosis	0.00257	0.00879	CbGeAlD
Pethidine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00254	0.01	CcSEcCtD
Pethidine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00985	CcSEcCtD
Pethidine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00248	0.00849	CbGeAlD
Pethidine—GRIN2A—central nervous system—amyotrophic lateral sclerosis	0.00247	0.00847	CbGeAlD
Pethidine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00963	CcSEcCtD
Pethidine—GRIN2A—cerebellum—amyotrophic lateral sclerosis	0.00242	0.00828	CbGeAlD
Pethidine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00947	CcSEcCtD
Pethidine—GRIN1—brain—amyotrophic lateral sclerosis	0.00236	0.00806	CbGeAlD
Pethidine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00913	CcSEcCtD
Pethidine—GRIN2B—brain—amyotrophic lateral sclerosis	0.00225	0.00769	CbGeAlD
Pethidine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0088	CcSEcCtD
Pethidine—OPRK1—nervous system—amyotrophic lateral sclerosis	0.0022	0.00751	CbGeAlD
Pethidine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00218	0.00747	CbGeAlD
Pethidine—OPRK1—central nervous system—amyotrophic lateral sclerosis	0.00211	0.00723	CbGeAlD
Pethidine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00209	0.00714	CbGeAlD
Pethidine—OPRK1—cerebellum—amyotrophic lateral sclerosis	0.00207	0.00707	CbGeAlD
Pethidine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00816	CcSEcCtD
Pethidine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00795	CcSEcCtD
Pethidine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00784	CcSEcCtD
Pethidine—GRIN2A—brain—amyotrophic lateral sclerosis	0.00196	0.00672	CbGeAlD
Pethidine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00732	CcSEcCtD
Pethidine—OPRM1—spinal cord—amyotrophic lateral sclerosis	0.00185	0.00634	CbGeAlD
Pethidine—ORM1—spinal cord—amyotrophic lateral sclerosis	0.00181	0.00619	CbGeAlD
Pethidine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00704	CcSEcCtD
Pethidine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00698	CcSEcCtD
Pethidine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00698	CcSEcCtD
Pethidine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00694	CcSEcCtD
Pethidine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00168	0.00576	CbGeAlD
Pethidine—OPRK1—brain—amyotrophic lateral sclerosis	0.00168	0.00574	CbGeAlD
Pethidine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00658	CcSEcCtD
Pethidine—OPRM1—nervous system—amyotrophic lateral sclerosis	0.00156	0.00535	CbGeAlD
Pethidine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00154	0.00528	CbGeAlD
Pethidine—ORM1—nervous system—amyotrophic lateral sclerosis	0.00152	0.00522	CbGeAlD
Pethidine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00152	0.00521	CbGeAlD
Pethidine—OPRM1—central nervous system—amyotrophic lateral sclerosis	0.0015	0.00515	CbGeAlD
Pethidine—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00147	0.00502	CbGeAlD
Pethidine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00142	0.00485	CbGeAlD
Pethidine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00137	0.00467	CbGeAlD
Pethidine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.00133	0.00457	CbGeAlD
Pethidine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.0013	0.00445	CbGeAlD
Pethidine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00428	CbGeAlD
Pethidine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.0012	0.00409	CbGeAlD
Pethidine—OPRM1—brain—amyotrophic lateral sclerosis	0.00119	0.00409	CbGeAlD
Pethidine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00114	0.00391	CbGeAlD
Pethidine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.0011	0.00377	CbGeAlD
Pethidine—SLC6A3—brain—amyotrophic lateral sclerosis	0.00108	0.00371	CbGeAlD
Pethidine—ALB—brain—amyotrophic lateral sclerosis	0.00102	0.0035	CbGeAlD
Pethidine—SLC6A4—brain—amyotrophic lateral sclerosis	0.000993	0.0034	CbGeAlD
Pethidine—SLC6A2—brain—amyotrophic lateral sclerosis	0.000874	0.00299	CbGeAlD
Pethidine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000843	0.00288	CbGeAlD
Pethidine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000812	0.00278	CbGeAlD
Pethidine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000644	0.0022	CbGeAlD
Pethidine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000636	0.00218	CbGeAlD
Pethidine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000626	0.00214	CbGeAlD
Pethidine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000613	0.0021	CbGeAlD
Pethidine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000603	0.00206	CbGeAlD
Pethidine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000589	0.00202	CbGeAlD
Pethidine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000479	0.00164	CbGeAlD
Pethidine—GRIN2B—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000371	0.000824	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000367	0.000815	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000367	0.000815	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.000366	0.000814	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000365	0.00081	CbGpPWpGaD
Pethidine—GRIN2C—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.00036	0.0008	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00036	0.0008	CbGpPWpGaD
Pethidine—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000359	0.000798	CbGpPWpGaD
Pethidine—SLC6A4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000357	0.000793	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000354	0.000788	CbGpPWpGaD
Pethidine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000351	0.00078	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00035	0.000779	CbGpPWpGaD
Pethidine—SLC6A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000347	0.000772	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000345	0.000766	CbGpPWpGaD
Pethidine—GRIN2D—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000335	0.000744	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000334	0.000742	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000326	0.000724	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000324	0.00072	CbGpPWpGaD
Pethidine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000322	0.000716	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000321	0.000713	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000319	0.000708	CbGpPWpGaD
Pethidine—GRIN1—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	0.000308	0.000683	CbGpPWpGaD
Pethidine—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000307	0.000682	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000301	0.00067	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000301	0.00067	CbGpPWpGaD
Pethidine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.0003	0.000666	CbGpPWpGaD
Pethidine—GRIN2B—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	0.0003	0.000666	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000298	0.000663	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000296	0.000657	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000292	0.00065	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000291	0.000647	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000284	0.000631	CbGpPWpGaD
Pethidine—GRIN1—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	0.000276	0.000614	CbGpPWpGaD
Pethidine—GRIN2A—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000275	0.000611	CbGpPWpGaD
Pethidine—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000275	0.000611	CbGpPWpGaD
Pethidine—SLC6A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000272	0.000604	CbGpPWpGaD
Pethidine—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000271	0.000603	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000271	0.000603	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.00027	0.000601	CbGpPWpGaD
Pethidine—GRIN2B—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	0.000269	0.000598	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000269	0.000597	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000262	0.000583	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000261	0.000579	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000256	0.00057	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000256	0.000568	CbGpPWpGaD
Pethidine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00025	0.000555	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000244	0.000541	CbGpPWpGaD
Pethidine—GRIN1—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.00024	0.000533	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000237	0.000527	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000235	0.000521	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000234	0.00052	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000233	0.000517	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000231	0.000514	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000226	0.000501	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000224	0.000498	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000222	0.000493	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000217	0.000482	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000215	0.000478	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000213	0.000473	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000213	0.000473	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000209	0.000464	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000198	0.00044	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000194	0.000431	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000191	0.000425	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00019	0.000423	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000189	0.000421	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000189	0.00042	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000186	0.000414	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000184	0.000409	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000183	0.000406	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000183	0.000406	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000181	0.000402	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000178	0.000395	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000174	0.000387	CbGpPWpGaD
Pethidine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000169	0.000376	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000168	0.000373	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000167	0.000371	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000163	0.000363	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000163	0.000362	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000163	0.000362	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000162	0.00036	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000162	0.00036	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000161	0.000358	CbGpPWpGaD
Pethidine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000161	0.000357	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00016	0.000355	CbGpPWpGaD
Pethidine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000158	0.000352	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000156	0.000347	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00015	0.000334	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000149	0.00033	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000148	0.00033	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000144	0.000321	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000138	0.000307	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000135	0.000299	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000134	0.000298	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000128	0.000283	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000127	0.000282	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000125	0.000279	CbGpPWpGaD
Pethidine—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000125	0.000277	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000123	0.000274	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000123	0.000274	CbGpPWpGaD
Pethidine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000121	0.00027	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000121	0.000269	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00012	0.000266	CbGpPWpGaD
Pethidine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00012	0.000266	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000115	0.000255	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000114	0.000254	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000114	0.000254	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000114	0.000253	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000113	0.000252	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000113	0.00025	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000112	0.000248	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000111	0.000248	CbGpPWpGaD
Pethidine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00011	0.000245	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000108	0.00024	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000105	0.000233	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000105	0.000233	CbGpPWpGaD
Pethidine—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000104	0.00023	CbGpPWpGaD
Pethidine—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000104	0.00023	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000103	0.000228	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000102	0.000226	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000102	0.000226	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.0001	0.000222	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.87e-05	0.000219	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	9.84e-05	0.000219	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	9.7e-05	0.000216	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	9.68e-05	0.000215	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.66e-05	0.000215	CbGpPWpGaD
Pethidine—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	9.48e-05	0.000211	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.35e-05	0.000208	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	9.3e-05	0.000207	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	9.3e-05	0.000207	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.19e-05	0.000204	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.19e-05	0.000204	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.06e-05	0.000201	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	8.97e-05	0.000199	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	8.9e-05	0.000198	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	8.87e-05	0.000197	CbGpPWpGaD
Pethidine—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.81e-05	0.000196	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.68e-05	0.000193	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	8.56e-05	0.00019	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	8.56e-05	0.00019	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	8.52e-05	0.000189	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	8.51e-05	0.000189	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	8.34e-05	0.000185	CbGpPWpGaD
Pethidine—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	8.29e-05	0.000184	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.19e-05	0.000182	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	8.15e-05	0.000181	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.04e-05	0.000179	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.95e-05	0.000177	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	7.95e-05	0.000177	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.91e-05	0.000176	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.91e-05	0.000176	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	7.83e-05	0.000174	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.66e-05	0.00017	CbGpPWpGaD
Pethidine—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	7.49e-05	0.000167	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	7.44e-05	0.000165	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	7.32e-05	0.000163	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.3e-05	0.000162	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.28e-05	0.000162	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.2e-05	0.00016	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	7.14e-05	0.000159	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	6.92e-05	0.000154	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	6.84e-05	0.000152	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.8e-05	0.000151	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	6.75e-05	0.00015	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	6.73e-05	0.00015	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.72e-05	0.000149	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.65e-05	0.000148	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.47e-05	0.000144	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	6.23e-05	0.000138	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	6.19e-05	0.000138	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.88e-05	0.000131	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	5.85e-05	0.00013	CbGpPWpGaD
Pethidine—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	5.68e-05	0.000126	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.62e-05	0.000125	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	5.6e-05	0.000124	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	5.6e-05	0.000124	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.47e-05	0.000122	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.46e-05	0.000121	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	5.24e-05	0.000117	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	5.24e-05	0.000116	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.12e-05	0.000114	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.12e-05	0.000114	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	5.11e-05	0.000114	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	5.1e-05	0.000113	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.97e-05	0.00011	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.88e-05	0.000108	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.77e-05	0.000106	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.76e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	4.7e-05	0.000105	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.69e-05	0.000104	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.62e-05	0.000103	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	4.52e-05	0.0001	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.47e-05	9.94e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.33e-05	9.63e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	4.33e-05	9.62e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	4.3e-05	9.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.28e-05	9.52e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.18e-05	9.29e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.13e-05	9.17e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.05e-05	8.99e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.93e-05	8.73e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.93e-05	8.73e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	3.86e-05	8.59e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.56e-05	7.92e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.55e-05	7.9e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.53e-05	7.85e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.53e-05	7.84e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.47e-05	7.72e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.32e-05	7.38e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.23e-05	7.18e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.07e-05	6.81e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.93e-05	6.52e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.83e-05	6.29e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.75e-05	6.11e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.73e-05	6.07e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.69e-05	5.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.67e-05	5.94e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.53e-05	5.61e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.42e-05	5.37e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.33e-05	5.17e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.32e-05	5.16e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.31e-05	5.14e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.26e-05	5.02e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.13e-05	4.72e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	2.08e-05	4.62e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.08e-05	4.62e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.06e-05	4.57e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.94e-05	4.32e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.91e-05	4.25e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.91e-05	4.24e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.76e-05	3.91e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.76e-05	3.9e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.75e-05	3.89e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.74e-05	3.88e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.74e-05	3.86e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.64e-05	3.65e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.57e-05	3.49e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.47e-05	3.28e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.44e-05	3.21e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.42e-05	3.16e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.32e-05	2.93e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.25e-05	2.78e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.2e-05	2.66e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	2.55e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.11e-05	2.48e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.08e-05	2.39e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.89e-06	2.2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	9.44e-06	2.1e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.47e-06	1.44e-05	CbGpPWpGaD
